Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
2,378,926
-
Share change
-
+415,917
-
Total reported value
-
$24,883,000
-
Price per share
-
$10.46
-
Number of holders
-
24
-
Value change
-
+$4,215,358
-
Number of buys
-
15
-
Number of sells
-
6
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q4 2016
As of 31 Dec 2016,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,378,926 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, MENORA MIVTACHIM HOLDINGS LTD., Migdal Insurance & Financial Holdings Ltd., Broadfin Capital, LLC, BANK HAPOALIM BM, SABBY MANAGEMENT, LLC, NEXTHERA CAPITAL LP, Candriam Luxembourg S.C.A., INGALLS & SNYDER LLC, and D.A. DAVIDSON & CO..
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.